Table 1 Clinical characteristics of SARS-CoV-2 infected people in a region of the Brazilian Amazon, 2020.

From: Risk factors associated with the severity of COVID-19 in a region of the Brazilian Amazon

Characteristics

Total of cases (N = 100,819)

Survival (N = 95,984)

Dead (N = 4835)

p-value

N

%

N

%

N

%

Symptoms

Fever

67,012

66.5

63,340

65.99

3672

75.95

< 0.0001

Cough

62,438

61.9

58,694

61.15

3744

77.44

< 0.0001

Pharyngalgia

40,138

39.8

38,861

40.49

1277

26.41

< 0.0001

Dyspnea

34,862

34.6

30,833

32.12

4029

83.33

< 0.0001

Headache

24,671

24.5

24,313

25.33

358

7.4

< 0.0001

Myalgia/arthralgya

17,963

17.8

17,555

18.29

408

8.44

< 0.0001

Diarrhea

9806

9.7

9383

9.78

423

8.75

0.02

Coryza

8603

8.5

8475

8.83

128

2.65

< 0.0001

Adynamia

4244

4.2

4099

4.27

145

3

< 0.0001

Nausea

3859

3.8

3598

3.75

261

5.4

< 0.0001

Chills

2342

2.3

2281

2.38

61

1.26

< 0.0001

Nasal congestion

1955

1.9

1881

1.96

74

1.53

0.0396

Odinophagy

963

1

930

0.97

33

0.68

0.0546

Conjunctivitis

199

0.2

191

0.2

8

0.17

0.7289

Comorbidities

Cardiovascular disease

5106

5.1

3963

4.13

1143

23.64

< 0.0001

Diabetes

4236

4.2

3211

3.35

1025

21.2

< 0.0001

Asthma

721

0.7

684

0.71

37

0.77

0.7366

Pulmonary disease

583

0.6

439

0.46

144

2.98

< 0.0001

Kidney disease

534

0.5

379

0.39

155

3.21

< 0.0001

Immunodeficiencies

442

0.4

328

0.34

114

2.36

< 0.0001

Obesity

365

0.4

241

0.25

124

2.56

< 0.0001

Neurological disease

186

0.2

92

0.1

94

1.94

< 0.0001

Hematological disease

56

0.1

42

0.04

14

0.29

< 0.0001

Liver disease

56

0.1

42

0.04

14

0.29

< 0.0001

  1. *G test.
Back to article page